Legal News

A look at what's going on with the Continuing Professional Development initiative from ACPE.

A new bimonthly column from Ken Baker looks at ethical decision-making in pharmacy.

The fungal meningitis outbreak can serve as a reminder of the need for risk management.

The Federal Trade Commission recently settled with a Puerto Rican pharmacy network that was allegedly engaging in noncompetitive behavior.

An Illinois appeals court recently upheld a ruling that pharmacists are permitted to refrain from prescribing emergency contraceptives, finding that healthcare professionals are protected by an Illinois state law.

Medication errors can't be completely eliminated, but can CQI programs keep them to a minimum?

Federal agencies have fined an LTC provider $50 million for improperly dispensing controlled substances.

What has staved off even higher levels of ongoing shortages is that drugmakers are reporting potential shortages much more often and FDA is using various tactics to prevent them from becoming reality.

That the Supreme Court upheld the Affordable Care Act bodes well for the generic drug market, which is already growing by leaps and bounds annually. Industry consultants expect ACA implementation to notably benefit retail pharmacists, PBMs, and drug wholesalers.

DEA published its interim final rule on e-prescribing for controlled substances (EPCS) more than two years ago. While vendors work toward compliance, nationwide deployment of EPCS can only occur once both state and federal laws are aligned in all jurisdictions.

The Office of Inspector General has issued a report implicating more than 2,600 pharmacies in Medicare Part D fraud

Pharmacy associations offered a range of comments after the Supreme Court ruling that upheld key elements of the Affordable Care Act

CMS is assessing genetic testing for the older population

Recent changes to Medicaid's reimbursement rules raise many confusing questions. Drug Topics' senior legal columnist sets out to clarify some key points

The National Rural Health Association recently sent a letter to U.S. Rep. Cathy McMorris Rodgers (R-WA) in support of the bill she introduced in March, H.R. 4215, or "The Medicare Pharmacy Transparency and Fair Auditing Act."

Okay, pharmacists. All together now. What's the one question you hear all day long?

Because their classification is variable, the taxation of glucose test strips varies from state to state, giving rise to massive confusion and loss of revenue

Ned Milenkovich has been reappointed to the Illinois State Board of Pharmacy for an additional five-year term

NABP has launched an initiative to transfer prescription monitoring program information across state lines

Connecticut's recently enacted law legalizing medical marijuana includes language ensuring that pharmacists who follow state law will be protected from prosecution

Cardinal Health this week settled litigation with the DEA, which suspended Cardinal?s ability to sell controlled substance medications from its Lakeland, Fla., distribution center for two years.

Accreditation standards guarantee reputation and high safety standards for compounding pharmacies.

One pharmacist argues that wanting to be called Doctor is more than just ego.

Four pharmacies have sued HHS and CMS to halt what they call a violation of federal Medicare Part D statute.

Healthcare industry experts discuss the pros and cons.

Pharmacists need additional guidance on the handling of biosimilar products in the pharmacy when these products become more widely available following the approval of the biosimilar pathway, said Marcie Bough, senior director of government affairs, APhA, speaking at an FDA hearing last week.

Connecticut's legislature passed a bill this weekend that would legalize the use of medical marijuana in the state. While several other states have similar laws, Connecticut is putting more restrictions on the dispensing of the drug.